Connect with us


HempMeds Latin American Operations, a subsidiary of Medical Marijuana, Inc. (OTCMKTS: MJNA), Announces a 12% Revenue Increase in June 2021 Compared to June 2020



What comes to mind when you hear the words, “Medical marijuana?” It is seemingly regarded as the United States’ fastest-growing industry today. Sadly, with a genuinely puzzling amount of incorrect information out there on the subject, it is essential to know and decide if medical marijuana is right for you. Medical Marijuana, Inc. (OTCMKTS: MJNA) has always envisioned a future where cannabis and Hemp could become a cornerstone of society. As a result, it was the first to launch the world’s first-ever cannabis-derived nutraceutical products. 

For the last couple of years, the cannabis company has built a global portfolio of brands led by Kannaway and HempMeds. 

June 2021 was the best month ever for the latter. The exclusive distributor for premium brands achieved its best revenue month ever in the history of the company. There was a 12 percent revenue increase compared to June 2020. In May 2021, the company increased its revenue by 84 percent. 

Applauding this milestone, HempMeds® CEO Raul Elizalde said, “This is a very exciting accomplishment and we hope that shareholders and customers alike can view this as a promising sign that our Company continues to expand on its international growth….”

Meanwhile, the company just signed a distribution agreement with a large retailer in Mexico to sell its CBD products nationwide. This includes RH Oil, which is the first-ever CBD product to be imported into Mexico, and doctors in Mexico recommend it. 

Think about a Future Where Hemp is a Staple in Diets

Medical Marijuana, Inc. believes that everyone can achieve a healthier existence through cannabis. Cannabinoids are the source of medicines being used to conquer some of the most debilitating diseases in the world. And as the demand for the use of cannabis evolves, Hemp is likely to become one of the most abundant crops in the world. 

In 2012, HempMeds, a Medical Marijuana, Inc. subsidiary, was the only company to have its CBD products listed in the Prescribers’ Digital Reference (PDR). Its operations are spread out in all 50 states and 40 countries.

*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.